← Leaderboards
Hicham M Drissi
Veterans Health Administration
$8,947,050
Attributed
$9,843,332
Total exposure
15
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,843,332 · 12
VA$0 · 3
By mechanism
R01$7,971,309 · 6
R21$1,509,023 · 4
R56$313,000 · 1
R13$50,000 · 1
I01$0 · 3
Top collaborators
- Joseph A Lorenzo6 shared
Most similar at Veterans Health Administration
Same institution · by research overlap
- Mervyn Neale Weitzmann$11,173,484
- Jeffry Stephen Nyman$7,533,465
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VivoHistologicMolecularIn VitroMediatingFractureRepairedChondrocytesTissuesReportingHealingBone MassHomeostasisStem CellsBone CallusLaser Capture MicrodissectionTranscription FactorImageExperimental StudySignal TransductionGenesProgenitorBone Regeneration
Grant awards (45)
Role of IL-17 receptor A in aging bone remodeling$450,806
R01 · FY2025 · AG · contact PI
Jagged1-based craniofacial bone regeneration$411,980
R01 · FY2025 · DE · contact PI
Control of intervertebral disc degeneration via matrix-mediated delivery of platelet-derived growth factors$355,188
R01 · FY2025 · AR · contact PI
Stem cell reprogramming for joint preservation to alleviate pain and promote function$0
I01 · FY2025 · VA · contact PI
Stem cell reprogramming for joint preservation to alleviate pain and promote function$0
I01 · FY2025 · VA · contact PI
Role of IL-17 receptor A in aging bone remodeling$474,110
R01 · FY2024 · AG · contact PI
Control of intervertebral disc degeneration via matrix-mediated delivery of platelet-derived growth factors$397,114
R01 · FY2024 · AR · contact PI
CMA: Cartilage Repair Strategies to Alleviate Arthritic Pain (CaRe AP): Novel cell-based therapies to increase functional outcomes and alleviate pain in preclinical models of osteoarthritis$0
I01 · FY2024 · VA · contact PI
Role of IL-17 receptor A in aging bone remodeling$428,901
R01 · FY2023 · AG · contact PI
Control of intervertebral disc degeneration via matrix-mediated delivery of platelet-derived growth factors$422,800
R01 · FY2023 · AR · contact PI
Bone anabolic effects of osteoclast-produced phospho-Wnt5a$313,000
R56 · FY2023 · AR · contact PI
Osteogenic and angiogenic tissue regeneration to accelerate secondary bone healing during aging$262,810
R01 · FY2023 · AG · contact PI
Spatial and Temporal Role of the Runx3 Transcription Factor in Secondary Fracture Healing$0
I01 · FY2023 · VA · contact PI
CMA: Cartilage Repair Strategies to Alleviate Arthritic Pain (CaRe AP): Novel cell-based therapies to increase functional outcomes and alleviate pain in preclinical models of osteoarthritis$0
I01 · FY2023 · VA · contact PI
Control of intervertebral disc degeneration via matrix-mediated delivery of platelet-derived growth factors$423,936
R01 · FY2022 · AR · contact PI
Osteogenic and angiogenic tissue regeneration to accelerate secondary bone healing during aging$262,810
R01 · FY2022 · AG · contact PI
Advances in Musculoskeletal & Neuronal Interactions$50,000
R13 · FY2022 · AG · contact PI
Spatial and Temporal Role of the Runx3 Transcription Factor in Secondary Fracture Healing$0
I01 · FY2022 · VA · contact PI
CMA: Cartilage Repair Strategies to Alleviate Arthritic Pain (CaRe AP): Novel cell-based therapies to increase functional outcomes and alleviate pain in preclinical models of osteoarthritis$0
I01 · FY2022 · VA · contact PI
Control of intervertebral disc degeneration via matrix-mediated delivery of platelet-derived growth factors$442,413
R01 · FY2021 · AR · contact PI
Osteogenic and angiogenic tissue regeneration to accelerate secondary bone healing during aging$262,810
R01 · FY2021 · AG · contact PI
Influence of the gut microbiome on normal and senile fracture healing$191,280
R21 · FY2021 · AG · contact PI
CMA: Cartilage Repair Strategies to Alleviate Arthritic Pain (CaRe AP): Novel cell-based therapies to increase functional outcomes and alleviate pain in preclinical models of osteoarthritis$0
I01 · FY2021 · VA · contact PI
Spatial and Temporal Role of the Runx3 Transcription Factor in Secondary Fracture Healing$0
I01 · FY2021 · VA · contact PI
Osteogenic and angiogenic tissue regeneration to accelerate secondary bone healing during aging$262,810
R01 · FY2020 · AG · contact PI
Influence of the gut microbiome on normal and senile fracture healing$230,620
R21 · FY2020 · AG · contact PI
Spatial and Temporal Role of the Runx3 Transcription Factor in Secondary Fracture Healing$0
I01 · FY2020 · VA · contact PI
Osteogenic and angiogenic tissue regeneration to accelerate secondary bone healing during aging$282,040
R01 · FY2019 · AG · contact PI
Identification of Chromatin Architecture at the RUNX1 locus that regulate bone formation and mineralization$149,146
R21 · FY2019 · AR · contact PI
Identification of Chromatin Architecture at the RUNX1 locus that regulate bone formation and mineralization$183,057
R21 · FY2018 · AR · contact PI
Runx1 Control of Bone Resorption during Fracture Repair$338,938
R01 · FY2017 · AR
Runx1 Control of Bone Resorption during Fracture Repair$338,938
R01 · FY2016 · AR
Use of hESC-Derived Progenitors for the Treatment of Degenerated Discs$171,600
R21 · FY2016 · AR · contact PI
Runx1 Control of Bone Resorption during Fracture Repair Supplement$100,000
R01 · FY2016 · AR · contact PI
Runx1 Control of Bone Resorption during Fracture Repair$338,938
R01 · FY2015 · AR · contact PI
Use of hESC-Derived Progenitors for the Treatment of Degenerated Discs$210,540
R21 · FY2015 · AR · contact PI
Runx1 Control of Bone Resorption during Fracture Repair$337,875
R01 · FY2014 · AR · contact PI
Runx1 Control of Bone Resorption during Fracture Repair$337,875
R01 · FY2013 · AR · contact PI
IDENTIFICATION OF DIFFERENTIALLY EXPRESSED CRITICAL GENES IN CHONDROCLASTS AND OS$166,230
R21 · FY2011 · AR · contact PI
IDENTIFICATION OF DIFFERENTIALLY EXPRESSED CRITICAL GENES IN CHONDROCLASTS AND OS$206,550
R21 · FY2010 · AR · contact PI
Runx-mediated regulation of endochondral ossification$242,042
R01 · FY2008 · AR · contact PI
Runx-mediated regulation of endochondral ossification$127,230
R01 · FY2007 · AR · contact PI
Runx-mediated regulation of endochondral ossification$126,277
R01 · FY2007 · AR · contact PI
Runx-mediated regulation of endochondral ossification$268,108
R01 · FY2006 · AR · contact PI
Runx-mediated regulation of endochondral ossification$274,560
R01 · FY2005 · AR